<?xml version="1.0" encoding="UTF-8"?>
<p>Nikolova et al. obtained Ru(III) complexes containing benzothiazole derivatives and tested their anticancer activity against K-562 and KE-37 (human leukemic) cell lines. Among all these derivatives, the Ru(III) containing methylbenzothiazole 
 <bold>60</bold> (
 <xref ref-type="fig" rid="F0037">Figure 37</xref>) exhibited the highest cytotoxic activity against K-562 and KE-37, having IC
 <sub>50</sub> values of 7.74 ± 2.50 for KE-37 and of 16.21 ± 2.33 for K-562 when compared with the standard drug cisplatin
 <xref rid="CIT0060" ref-type="bibr">
  <sup>60</sup>
 </xref>.
</p>
